BLOG / 🇮🇳 India / distress insolvency · · daily

India NCLT Insolvency Resolution Filings — November 05, 2026

India Corporate Insolvency & NCLT

By Gunpowder Editorial ·

7 high priority 7 total filings analysed

Executive Summary

The India Corporate Insolvency & NCLT stream for 5 November 2026 covers a cluster of distressed and restructuring situations.

The most material developments are Quadrant Televentures (CIRP since September 2025, only about 48% of ₹59,166 Cr claims admitted, with unsecured financial creditors admitted at just 8.8%) and Quasar India (fresh CIRP commencement on 31 October 2026, with an interim resolution professional appointed and a claims deadline of 14 November 2026). Simbhaoli Sugars is in an extended CIRP with its resolution plan deadline pushed to 21 November 2026 and cane-allocation appeals pending before the Allahabad High Court. SAB Events & Governance Now Media shows modestly narrowing losses (H1 FY27 net loss ₹27.15 Lakh vs ₹38.31 Lakh) and revenue growth of 2.8% YoY, but carries negative net worth of ₹(268.47) Lakh, current liabilities at 5.41x current assets, and a going-concern qualification while its PPIRP plan is implemented. Positive legal and governance outcomes include the NCLAT annulling the CIRP against Shilpa Medicare's subsidiary FTF Pharma (no quantifiable impact on the listed parent) and Go Digit's amalgamation scheme clearing shareholder approval with about 99.999% of public votes in favour. Punj Lloyd's RTA address change is administrative only. Enriched period-over-period financials were available only for SAB Events, so cross-company margin and growth comparisons are limited; the dominant theme is that resolution timelines are slipping and creditor claim admission is contested.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: Insolvency · Corporate governance

Tracking the trend? Catch up on the prior India NCLT Insolvency Resolution Filings digest from November 04, 2026.

Investment Signals (7)

  • ▲

    NCLAT set aside the NCLT Ahmedabad admission of CIRP against wholly owned subsidiary FTF Pharma (order dated 4 Nov 2026); company states no quantifiable impact on the listed entity, removing a contingent overhang

  • Equity shareholders approved the Scheme of Amalgamation with Go Digit Infoworks at the NCLT-convened meeting on 5 Nov 2026, with ~99.999% of public votes in favour and ~91.76% of public shares participating; no cash consideration payable, share exchange ratio applies

  • Q2 FY27 net loss narrowed to ₹0.30 Lakh from ₹4.01 Lakh YoY and H1 FY27 revenue rose 2.8% YoY to ₹9,862 Lakh, but equity fell further to ₹(268.47) Lakh from ₹(241.33) Lakh since March 2026

  • Only ₹28,16,83,42,464 of ₹59,16,41,64,891 total claims (about 48%) admitted; unsecured financial creditor admission at 8.8% (₹1,59.85 Cr admitted of ₹1,811.41 Cr claimed) signals severe recovery uncertainty for lenders

  • Secured financial creditors show 85.1% admission (₹703.55 Cr of ₹826.69 Cr), indicating a relatively stronger position for secured lenders versus unsecured creditors in the same CIRP

  • CoC extended the resolution plan submission deadline from 5 Nov to 21 Nov 2026, a second signal of timeline slippage under CIRP effective since 11 July 2024

  • ▲

    Fresh CIRP commenced 31 Oct 2026 with interim resolution professional Raghunath Sabanna Bhandari; estimated process closure 29 Apr 2027; no financial results disclosed, so downside cannot be quantified from this filing

Risk Flags (7)

  • Unsecured financial claims of ₹1,811.41 Cr with only 8.8% admitted and roughly ₹59,166 Cr total claims against a 14-month-old CIRP; recovery visibility is low

  • ▼

    Auditors flagged material uncertainty over going concern; current liabilities 5.41x current assets; negative net worth deepened to ₹(268.47) Lakh as at 30.09.2026

  • PPIRP plan approved by NCLT Mumbai on 10 July 2026 with capital reduction still in progress; execution risk remains high given negative equity

  • CIRP commenced 31 Oct 2026, claims deadline 14 Nov 2026 (about nine days after the disclosure window), and financial creditors must file claims electronically only; creditor-side action is time-critical

  • Pending cane allocation appeals before Hon'ble Allahabad High Court may complicate the resolution plan's valuation and bidder appetite

  • ▼

    Board powers suspended under CIRP; Interim Resolution Professional Mr. Anurag Goel controls decisions, limiting shareholder influence on the outcome

  • ▼

    The NCLAT annulment can still be challenged further, and the underlying dispute (disputed Technology Transfer Agreement milestone payments and a disputed third-party testing invoice) remains unresolved

Opportunities (6)

  • NCLAT annulment of the FTF Pharma CIRP with no quantifiable impact on the listed entity; the disputed operational creditor claim (Immacule Lifesciences) becomes a settlement candidate with limited downside to the parent

  • Public shareholder approval at ~99.999% in favour clears a key hurdle; subsequent NCLT sanction and regulatory approvals (IRDAI advisory already reflected in scheme modifications) are the next catalysts

  • Secured creditor claims show 85.1% admission, suggesting resolution value may accrue preferentially to secured lenders; distressed-debt investors can target secured claims over unsecured ones

  • Extended submission deadline of 21 Nov 2026 gives prospective resolution applicants time to bid; cane-allocation appeal outcome before the Allahabad High Court is a key valuation swing factor

  • Losses narrowed sharply (Q2 net loss ₹0.30 Lakh vs ₹4.01 Lakh YoY) and revenue grew 2.8% in H1; successful PPIRP implementation could restore a positive equity base for a small-cap turnaround

  • Newly commenced CIRP with claims window open until 14 Nov 2026; creditors with claim documentation can position early before admission outcomes are known

Sector Themes (5)

  • Contested Claim Admission in Large CIRPs (HIGH IMPACT)
    ◆

    Quadrant Televentures shows admission rates diverging sharply by creditor class (secured 85.1% vs unsecured 8.8%), indicating that claim-verification disputes are a systemic recovery drag for unsecured creditors in IBC proceedings

  • Resolution Timeline Slippage (HIGH IMPACT)
    ◆

    Simbhaoli Sugars extended its plan deadline by 16 days and remains in CIRP since July 2024 (over two years), while Quadrant has run 14 months; extended timelines are eroding enterprise value and creditor recoveries

  • Parent Protection via Subsidiary Litigation (MEDIUM IMPACT)
    ◆

    Shilpa Medicare's NCLAT outcome illustrates how listed parents can ring-fence exposure when a wholly owned subsidiary enters CIRP, through appellate reversal and disclosure that no quantifiable impact exists

  • Restructuring via Schemes and Plans (MEDIUM IMPACT)
    ◆

    Go Digit's amalgamation and SAB Events' PPIRP show NCLT-supervised restructuring (merger schemes and pre-packaged or pre-pack-style plans) being used both for healthy consolidation and distressed rescue, with capital reduction as a common execution step

  • Negative Equity as an Early-Warning Signal (MEDIUM IMPACT)
    ◆

    SAB Events' equity deterioration to ₹(268.47) Lakh alongside going-concern uncertainty and 5.41x current liability coverage reflects the liquidity-equity squeeze typical of companies entering insolvency or PPIRP processes

Watch List (7)

  • Financial creditors must file claims electronically by 14 Nov 2026; monitor the interim resolution professional's first CoC constitution and claim verification timeline (process closure estimated 29 Apr 2027)

  • Plan submission deadline 21 Nov 2026; watch for bidder participation, any further extension, and the Allahabad High Court ruling on cane allocation appeals

  • Revised creditor list follows NCLT Mumbai Bench-I order of 3 Nov 2026; monitor further claim admissions in unsecured categories and the eventual resolution plan submissions

  • Post shareholder approval, monitor NCLT Mumbai's sanction hearing for the Scheme of Amalgamation with Go Digit Infoworks and related IRDAI clearances

  • Monitor the Q3 FY27 filing for current-liability coverage, net worth trajectory, and progress on capital reduction under the NCLT-approved PPIRP plan (approved 10 Jul 2026)

  • Monitor whether the Immacule Lifesciences side or the Ahmedabad NCLT seeks further appellate relief against the 4 Nov 2026 NCLAT order, and the status of the disputed Technology Transfer Agreement milestone payments

  • Routine, but confirm the RTA change to KFin Technologies' Kokapet office effective 1 Dec 2026 is completed without shareholder-servicing disruption

Filing Analyses (7)
Shilpa Medicare Limited Insolvency positive materiality 4/10

05-11-2026

Shilpa Medicare Limited disclosed that the National Company Law Appellate Tribunal (NCLAT), New Delhi, by order dated 4 November 2026, set aside the NCLT Ahmedabad Bench order dated 9 September 2026 that had admitted Corporate Insolvency Resolution Process (CIRP) proceedings against FTF Pharma Private Limited, its wholly owned subsidiary, and consequently the CIRP stands annulled. The company states there is no quantifiable impact on the listed entity from the earlier order being annulled. The appeal was filed by Mr. Abhay Sapre, a suspended director of FTF Pharma, against the operational creditor Immacule Lifesciences Private Limited.

  • · NCLAT order dated 4 November 2026 in Comp. App. (AT) (Ins) No. 1781 of 2026 set aside the NCLT Ahmedabad order dated 9 September 2026 (C.P. (IB) No. 346 (Ahm) of 2025)
  • · Company received the order on 5 November 2026 and disclosed it under Regulation 30 of SEBI Listing Regulations
  • · Company states the appeal's underlying dispute concerns a Technology Transfer Agreement with an operational creditor, with disputed milestone payments and a disputed invoice for third-party testing
  • · Annulment of CIRP is characterised by the company as having no impact on the listed entity
Sab Events & Governance Now Media Limited Corporate Governance mixed materiality 8/10

05-11-2026

SAB Events & Governance Now Media reported Q2 FY27 revenue from operations of ₹5,326 Lakh, down 3.6% YoY from ₹5,525 Lakh, while narrowing its net loss to ₹0.30 Lakh from ₹4.01 Lakh in Q2 FY26. For H1 FY27, revenue rose 2.8% YoY to ₹9,862 Lakh and the net loss narrowed to ₹27.15 Lakh from ₹38.31 Lakh. However, the company remains under severe financial stress: current liabilities are 5.41 times current assets, net worth is negative at ₹(268.47) Lakh, and the auditors flagged material uncertainty over going concern, with implementation of the NCLT-approved PPIRP Resolution Plan (order dated July 10, 2026) still in progress.

  • · Current liabilities are 5.41 times current assets as on 30 September 2026, with negative net worth — auditors flagged material uncertainty over going concern.
  • · NCLT Mumbai Bench approved the PPIRP Resolution Plan on July 10, 2026; implementation including capital restructuring/reduction is in progress.
  • · Total equity fell to ₹(268.47) Lakh as at 30.09.2026 from ₹(241.33) Lakh as at 31.03.2026.
  • · Trade receivables declined to ₹25.21 Lakh from ₹54.20 Lakh; cash and cash equivalents rose to ₹13.15 Lakh from ₹6.78 Lakh.
  • · Borrowings fell sharply to ₹1.00 Lakh from ₹200.71 Lakh as at 31.03.2026.
  • · Net cash generated from operating activities was ₹206.37 Lakh for H1 FY27 versus ₹4.45 Lakh for FY26.
  • · Employee benefit expense rose to ₹43.58 Lakh in H1 FY27 from ₹38.93 Lakh in H1 FY26.
  • · Company operates in a single segment: Digital Media Websites & MICE.
  • · Results reviewed by statutory auditors P. Parikh & Associates and approved by the Board on 5 November 2026.
Quasar India Limited Insolvency negative materiality 9/10

05-11-2026

Quasar India Limited disclosed to BSE that the National Company Law Tribunal (NCLT), New Delhi Bench, Court-V, has ordered the commencement of a Corporate Insolvency Resolution Process (CIRP) against the company, with an order date of 31 October 2026. Raghunath Sabanna Bhandari has been appointed Interim Resolution Professional, and creditors are required to submit claims with proof by 14 November 2026. The filing contains no quantitative financial results, so no period-over-period performance comparison is available.

  • · Insolvency commencement order dated 31-10-2026, uploaded to NCLT website on 03-11-2026
  • · Estimated closure date of the insolvency resolution process: 29-04-2027
  • · Claims submission deadline: 14 November 2026; financial creditors must file claims electronically only
  • · Public announcements published 5 November 2026 in Financial Express (New Delhi, English) and Jansatta (New Delhi, Hindi)
  • · Company's incorporation date: 19-04-1979; CIN L67190DL1979PLC009555; registered office in New Delhi
  • · Filing made under Regulation 30 of SEBI (LODR) Regulations, 2015, following an earlier intimation on 04 November 2026
Go Digit General Insurance Limited Insolvency positive materiality 7/10

05-11-2026

Go Digit General Insurance Limited announced that equity shareholders approved the Scheme of Amalgamation with its wholly owned subsidiary-type transferor Go Digit Infoworks Services Private Limited at a NCLT-convened meeting held on 5 November 2026. Resolution No. 1 cleared the requisite majority, and the public shareholder majority test was also met, with about 99.999% of public votes cast in favour of the Scheme (approximately 91.76% of public shares participated). Promoter and promoter group votes were recorded at 0 in favour and 0 against in the tables, while the promoter group holding (approximately 67.5 crore shares) was excluded from the vote count under Regulation 23(4) of the SEBI Listing Regulations and Section 188(1) of the Companies Act.

  • · The NCLT Mumbai Bench order approving the convening of the meeting is dated 13 August 2026
  • · The meeting ran from 11:00 a.m. to 11:25 a.m. IST via VC/OAVM and was held in the NCLT-appointed presence
  • · No cash consideration is payable under the Scheme; the share exchange ratio applies and the Scheme was modified per IRDAI regulatory advisory
  • · Remote e-voting ran from 1 November 2026 (9:00 a.m. IST) to 4 November 2026 (5:00 p.m. IST), with a record date of 29 October 2026
  • · Scheme approval also requires the Insurance Act, 1938 regulatory approval framework, and the scheme is being disclosed under Regulation 30 read with Schedule III of SEBI LODR
Simbhaoli Sugars Limited Insolvency neutral materiality 7/10

05-11-2026

Simbhaoli Sugars Limited has filed a post-facto intimation of the 5th Meeting of its Committee of Creditors (CoC), held on 04 November 2026 under Section 24 of the IBC, 2016. The CoC extended the last date for submission of Resolution Plans from 05 November 2026 to 21 November 2026 and received an update on cane allocation appeals pending before the Hon'ble Allahabad High Court. The company remains under Corporate Insolvency Resolution Process (CIRP) effective 11 July 2024, with Mr. Anurag Goel as Interim Resolution Professional managing its affairs.

  • · CIRP was initiated w.e.f. 11 July 2024 via adjudicating authority order dated 11 July 2024; Board of Directors powers are suspended
  • · Resolution Plan submission deadline extended from 05 November 2026 to 21 November 2026
  • · CoC update included pending cane allocation appeals before the Hon'ble Allahabad High Court
Quadrant Televentures Limited Insolvency negative materiality 10/10

05-11-2026

Quadrant Televentures Limited has submitted a revised list of creditors to the stock exchanges following an order dated November 3, 2026 from the National Company Law Tribunal (NCLT), Mumbai Bench-I, under Section 7 of the Insolvency and Bankruptcy Code, 2016. The company is undergoing Corporate Insolvency Resolution Process (CIRP) which commenced on September 2, 2025. Total claims received amount to ₹59,16,41,64,891, of which only ₹28,16,83,42,464 (about 48%) have been admitted, with a significant portion of claims being disputed or not admitted, indicating a highly distressed financial position.

  • · The CIRP commenced on September 2, 2025, over 14 months before this filing.
  • · Secured financial creditors (6 claims) have a high admission rate of 85.1% with ₹7,03,54,94,966 admitted out of ₹8,26,68,97,369 claimed.
  • · Unsecured financial creditors (2 claims) have a very low admission rate of 8.8% with only ₹1,59,85,00,000 admitted out of ₹18,11,40,84,601 claimed.
  • · Operational creditors (Government Dues) have a low admission rate of 24.6% with ₹2,84,77,79,811 admitted out of ₹11,58,73,35,604 claimed.
  • · Other operational creditors (329 claims) have a moderate admission rate of 54.5% with ₹2,30,65,58,557 admitted out of ₹4,23,05,34,571 claimed.
  • · Other creditors (5 claims) have a high admission rate of 84.7% with ₹14,37,92,02,400 admitted out of ₹16,96,45,06,016 claimed.
  • · All secured creditors' claims are secured by a first pari-passu charge on the company's immovable and movable properties, including book debts and other current assets.
  • · Personal guarantees have been provided by Mr. P. N. Dhoot and Mr. V. N. Dhoot for the secured debt.
  • · A Mexican company, TDM International, S.A. de CV, has consented to mortgage its property in Mexico to secure the outstanding debt of the corporate debtor.
  • · The largest secured creditor is IDBI Bank Limited (through IDBI Trusteeship Service Limited) with an admitted claim of ₹4,32,88,53,026 (61.53% voting share in CoC).
  • · The largest unsecured financial creditor is Akai Consumer Electronics Indian Limited with an admitted claim of ₹1,59,85,00,000.
  • · The largest operational creditor (Government Dues) is the Ministry of Communications (DDG, Department of Telecommunications) with an admitted claim of ₹2,84,77,79,811.
  • · Employee claims (27 claims) are fully admitted at ₹8,06,730.
  • · No claims from workmen or secured/unsecured financial creditors belonging to any class of creditors were reported.
Punj Lloyd Ltd Insolvency neutral materiality 1/10

05-11-2026

Punj Lloyd Ltd has informed stock exchanges that its Registrar and Share Transfer Agent (RTA), KFin Technologies Limited, will change its corporate office address effective December 1, 2026. The new address is in Kokapet, Telangana, with all other RTA details unchanged. This is a routine administrative update with no financial impact.

  • · New RTA corporate office address: 6,23,24, 25th Floor, South Tower, Rajapushpa West Avenue, Survey No. 115, Kokapet, Serilingampally Mandal, Ranga Reddy District, Telangana - 500075
  • · RTA contact: Telephone 081210 13657, Email [email protected], Website www.kfintech.com
  • · Change effective from December 1, 2026
  • · Company scrip code: 532693 (BSE), Symbol: PUNJLLOYD (NSE)

Get daily alerts with 7 investment signals, 7 risk alerts, 6 opportunities and full AI analysis of all 7 filings

₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: India NCLT Insolvency Resolution Filings

🇮🇳 More from India

View all →